Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08) (English, HTML)

Notice: Prescription Drug List (PDL): Multiple Additions (2020-09-08): English HTML file. From Health Canada, updated Oct 2023. View metadata, licence and the direct download on CanQuery.

Format
HTML
Access
Original download only
Publisher-reported update
2023-10-01

The purpose of this Notice of Amendment is to notify about the additions of amifampridine, cedazuridine (when used in combination with another drug), etomidate, fedratinib, lefamulin, obiltoxaximab, polatuzumab vedotin, ripretinib, satralizumab and sonidegib to the Prescription Drug List (PDL) for human and/or veterinary use.

Access original file

Data overview

Formats
HTML
File languages
English
Available actions
Access original file

Official sources and licences

Related open data